Bioinformatics Methodologies to Identify Interactions Between Type 2 Diabetes and Neurological Comorbidities
暂无分享,去创建一个
Silong Peng | Chen Chen | Shahadat Uddin | Julian M. W. Quinn | Xiyuan Hu | Julian M. W. Quinn | Mohammad Ali Moni | Md Habibur Rahman | S. Peng | Xiyuan Hu | S. Uddin | Chen Chen | M. Moni | J. Quinn | M. Rahman | Silong Peng
[1] S. Bonner-Weir,et al. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. , 1983, The Journal of clinical investigation.
[2] J. Leahy,et al. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. , 1986, The Journal of clinical investigation.
[3] R. DeFronzo,et al. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.
[4] Yii-Der I. Chen,et al. Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.
[5] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[6] K. Walker,et al. Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat. , 1996, The American journal of clinical nutrition.
[7] C. Steiner,et al. Comorbidity measures for use with administrative data. , 1998, Medical care.
[8] E. Cerasi,et al. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.
[9] K. Maedler,et al. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. , 2001, Diabetes.
[10] Joseph L Evans,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.
[11] D. Ron,et al. Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.
[12] P. Halban,et al. Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. , 2003, Diabetes.
[13] M. Donath,et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. , 2003, Diabetes.
[14] I. Goldfine,et al. Are Oxidative StressActivated Signaling Pathways Mediators of Insulin Resistance and -Cell , 2003 .
[15] Joseph L Evans,et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.
[16] Masataka Mori,et al. Endoplasmic reticulum stress and diabetes mellitus. , 2003, Internal medicine.
[17] G. Stephanopoulos,et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. , 2004, Physiological genomics.
[18] W. Markesbery,et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Bonner-Weir,et al. Five Stages of Evolving-Cell Dysfunction During Progression to Diabetes , 2004 .
[20] R V Jensen,et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Sebastiano Cavallaro,et al. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis , 2007, BMC Genomics.
[23] D. Maraganore,et al. A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease , 2007, PLoS genetics.
[24] Philip S. Yu,et al. A new method to measure the semantic similarity of GO terms , 2007, Bioinform..
[25] Sean R. Davis,et al. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..
[26] R. Robertson,et al. Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .
[27] V. Kostic,et al. Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. , 2008, Archives of neurology.
[28] Catia Pesquita,et al. Metrics for GO based protein semantic similarity: a systematic evaluation , 2008, BMC Bioinformatics.
[29] Lucas R. Smith,et al. Novel transcriptional profile in wrist muscles from cerebral palsy patients , 2009, BMC Medical Genomics.
[30] O. Maes,et al. Methodology for discovery of Alzheimer's disease blood-based biomarkers. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[31] Albert-László Barabási,et al. A Dynamic Network Approach for the Study of Human Phenotypes , 2009, PLoS Comput. Biol..
[32] B. Spann,et al. Transcriptome Analysis of Synaptoneurosomes Identifies Neuroplasticity Genes Overexpressed in Incipient Alzheimer's Disease , 2009, PloS one.
[33] L. Mucke,et al. Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.
[34] Ayellet V. Segrè,et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.
[35] Yibo Wu,et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products , 2010, Bioinform..
[36] G. Petsko,et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease , 2010, Proceedings of the National Academy of Sciences.
[37] Lorella Marselli,et al. 1 CLASS II PHOSPHOINOSITIDE 3-KINASE REGULATES EXOCYTOSIS OF INSULIN GRANULES IN PANCREATIC BETA CELLS , 2010 .
[38] Dennis C. Sgroi,et al. Gene Expression Profiles of Beta-Cell Enriched Tissue Obtained by Laser Capture Microdissection from Subjects with Type 2 Diabetes , 2010, PloS one.
[39] Manuel B. Graeber,et al. PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.
[40] Paul G. Ince,et al. Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS) , 2010, PloS one.
[41] R. L. Hull,et al. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? , 2010, Diabetologia.
[42] R. Kofler,et al. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells , 2010, BMC Cancer.
[43] M. Honda,et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.
[44] Anjana Munshi,et al. Genes associated with Alzheimer Disease , 2010 .
[45] G. Hotamisligil,et al. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.
[46] Mario Inostroza-Ponta,et al. A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis , 2010, PloS one.
[47] Gary D. Bader,et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..
[48] Panos N. Papapanou,et al. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases , 2011, Nature Reviews Endocrinology.
[49] R. Mechelli,et al. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. , 2011, Brain : a journal of neurology.
[50] S. Shoelson,et al. Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.
[51] H. D. Rosas,et al. Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse , 2011, Proceedings of the National Academy of Sciences.
[52] T. Gasser,et al. The Application of Clinical Genetics Dovepress Genetic Basis of Parkinson's Disease: Inheritance, Penetrance, and Expression , 2022 .
[53] Eric M. Blalock,et al. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.
[54] J. Kaprio,et al. Systematic review of genome-wide expression studies in multiple sclerosis , 2011, BMJ Open.
[55] S. Baranzini. Revealing the genetic basis of multiple sclerosis: are we there yet? , 2011, Current opinion in genetics & development.
[56] L. Defebvre,et al. Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation , 2011, Neurobiology of Aging.
[57] S. Greenberg,et al. Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells , 2012, Journal of Neuroimmunology.
[58] J. Epplen,et al. Genetic modifiers of Huntington’s disease: beyond CAG , 2012 .
[59] Lucas R. Smith,et al. Transcriptional Abnormalities of Hamstring Muscle Contractures in Children with Cerebral Palsy , 2012, PloS one.
[60] Tanya Barrett,et al. Strategies to explore functional genomics data sets in NCBI's GEO database. , 2012, Methods in molecular biology.
[61] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[62] M. Kubo,et al. Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis , 2012, The Journal of Immunology.
[63] W. Le,et al. Genetics of amyotrophic lateral sclerosis: an update , 2013, Molecular Neurodegeneration.
[64] Yvonne W. Cheng,et al. Maternal diagnosis of obesity and risk of cerebral palsy in the child. , 2013, The Journal of pediatrics.
[65] Charles Wang,et al. Transcriptomic Profiling of Human Peritumoral Neocortex Tissues Revealed Genes Possibly Involved in Tumor-Induced Epilepsy , 2013, PloS one.
[66] Sandeep Kumar Mathur,et al. Systems Biology Approach Reveals Genome to Phenome Correlation in Type 2 Diabetes , 2013, PloS one.
[67] Omar Ali,et al. Genetics of type 2 diabetes. , 2013, World journal of diabetes.
[68] Pietro Lio',et al. Comorbidity: a multidimensional approach. , 2013, Trends in molecular medicine.
[69] A. Kong,et al. Diabetes and its comorbidities—where East meets West , 2013, Nature Reviews Endocrinology.
[70] J. Nielsen,et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics* , 2013, Molecular & Cellular Proteomics.
[71] R. Reynolds,et al. Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions , 2014, Glia.
[72] S. Limborska,et al. Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson's Disease , 2014, BioMed research international.
[73] J. Nielsen,et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.
[74] M. Farrer,et al. Genetics and genomics of Parkinson’s disease , 2014, Genome Medicine.
[75] Pietro Liò,et al. comoR: a software for disease comorbidity risk assessment , 2014, Journal of Clinical Bioinformatics.
[76] N. Pochet,et al. Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice , 2015, Annals of neurology.
[77] A. Oliveira,et al. Clinical and genetic basis of familial amyotrophic lateral sclerosis. , 2015, Arquivos de neuro-psiquiatria.
[78] C. Mungall,et al. Gene Ontology Consortium : going forward The Gene Ontology , 2015 .
[79] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[80] Raphael Gottardo,et al. Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.
[81] W. Robberecht,et al. The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs , 2015 .
[82] W. Ye,et al. Association between diabetes and amyotrophic lateral sclerosis in Sweden , 2015, European journal of neurology.
[83] M. Rattray,et al. C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis , 2015, PloS one.
[84] H. Mefford,et al. Advancing epilepsy genetics in the genomic era , 2015, Genome Medicine.
[85] Pietro Liò,et al. CytoCom: a Cytoscape app to visualize, query and analyse disease comorbidity networks , 2015, Bioinform..
[86] P. De Meyts,et al. p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients. , 2015, American journal of physiology. Endocrinology and metabolism.
[87] P. Lio’,et al. How to build personalized multi-omics comorbidity profiles , 2015, Front. Cell Dev. Biol..
[88] S. Illarioshkin,et al. Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons , 2016, Molecular Neurodegeneration.
[89] Minoru Kanehisa,et al. KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..
[90] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[91] J. Gécz,et al. The genetic basis of cerebral palsy , 2017, Developmental medicine and child neurology.
[92] Andrew Steptoe,et al. Type 2 diabetes mellitus and psychological stress — a modifiable risk factor , 2017, Nature Reviews Endocrinology.
[93] M. Schachner,et al. Homophilic binding of the neural cell adhesion molecule CHL1 regulates development of ventral midbrain dopaminergic pathways , 2017, Scientific Reports.
[94] M. Keske,et al. A New Method for Targeted and Sustained Induction of Type 2 Diabetes in Rodents , 2017, Scientific Reports.
[95] V. Mohan,et al. Prevalence of type 2 diabetes and its complications in India and economic costs to the nation , 2017, European Journal of Clinical Nutrition.
[96] Chung-Yi Li,et al. A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus , 2017, Journal of epidemiology.
[97] Simon Hametner,et al. Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis , 2017, Brain : a journal of neurology.
[98] Mohammad Ali Moni,et al. Network-based identification of genetic factors in Ageing, lifestyle and Type 2 Diabetes that Influence in the progression of Alzheimer’s disease , 2018 .
[99] Md. Rezanur Rahman,et al. Common molecular biomarker signatures in blood and brain of Alzheimer’s disease , 2018, bioRxiv.
[100] Mohammad Ali Moni,et al. Genetic effect of Type 2 diabetes to the progression of neurological diseases , 2018 .
[101] Laura Inés Furlong,et al. comoRbidity: an R package for the systematic analysis of disease comorbidities , 2018, Bioinform..
[102] B. Ritz,et al. Type 2 Diabetes Mellitus and Alzheimer’s Disease: Overlapping Biologic Mechanisms and Environmental Risk Factors , 2018, Current Environmental Health Reports.
[103] R. Jockers,et al. Melatonin in type 2 diabetes mellitus and obesity , 2018, Nature Reviews Endocrinology.
[104] John Hardy,et al. The genetic landscape of Alzheimer disease. , 2018, Handbook of clinical neurology.
[105] Mohammad Ali Moni,et al. A System Biology Approach to Identify the Genetic Markers to the progression of Parkinson's disease for Aging, lifestyle and Type 2 Diabetes , 2018 .
[106] Mohammad Ali Moni,et al. Detection of multiple sclerosis using blood and brain cells transcript profiles: Insights from comprehensive bioinformatics approach , 2019, Informatics in Medicine Unlocked.
[107] Mohammad Ali Moni,et al. A computational approach to identify blood cell-expressed Parkinson's disease biomarkers that are coordinately expressed in brain tissue , 2019, Comput. Biol. Medicine.
[108] Laura I. Furlong,et al. Comorbidity4j: a tool for interactive analysis of disease comorbidities over large patient datasets , 2019, Bioinform..
[109] Pietro Liò,et al. Genetic Effects of Welding Fumes on the progression of Neurodegenerative Diseases , 2018, bioRxiv.
[110] Mohammad Ali Moni,et al. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease , 2019, Comput. Biol. Chem..
[111] Julian M. W. Quinn,et al. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective. , 2020, Genomics.
[112] Mohammad Ali Moni,et al. Discovering Biomarkers and Pathways Shared by Alzheimer’s Disease and Ischemic Stroke to Identify Novel Therapeutic Targets , 2019, Medicina.
[113] Mohammad Ali Moni,et al. Identification of molecular signatures and pathways common to blood cells and brain tissue of amyotrophic lateral sclerosis patients , 2019, Informatics in Medicine Unlocked.
[114] Julian M. W. Quinn,et al. Network‐based computational approach to identify genetic links between cardiomyopathy and its risk factors , 2020, IET systems biology.